The Cuban Experience
In October and November 2007, three provinces of the eastern region of Cuba were affected by strong rainfalls causing widespread floods severe damage to sanitary and health systems. The risk of leptospirosis infection was raised to extremely dangerous levels with about 2 million of people exposed to potentially contaminated water. The Finlay Institute (which manufactures vaccines for South America and Africa) prepared a leptospira nosode 200 CH using 4 circulating strains and following international quality standards. A multidisciplinary team travelled to the affected regions to conduct the massive administration of the nosode. Coordinated action with public health system infrastructures allowed the administration of a preventive treatment. Prevention consisted of two doses (7- 9 days apart) of the nosode to over 2.2 million of people (4.5 million doses). The coverage of the intervention rose up to 95% of total population of the three provinces most at risk.
The epidemiology surveillance after the intervention showed a dramatic decrease of morbidity two weeks after and a reduction to zero mortality of hospitalized patients. The number of confirmed leptospirosis cases remains at low levels, and below the expected levels according to the trends and rain regimens. A reinforcing application of nearly 4,500,000 doses was given in 2008 after the hit of the hurricane IKE but using the nosode potentized to 10-MCH. Strict epidemiologic surveillance was carried out on the targeted provinces. Published results show that the incidence of the disease was unchanged in the three intervened regions (the 3 regions most at risk due to the greatest level of hurricane damage), but rose significantly in the rest of the country where the HP program was not used. It provided overwhelming evidence of the effectiveness of the HP intervention. As a consequence, the Cuban Government directed the Finlay Institute to homeopathically immunise the entire country over 12 months of age against Swine Flu in 2009/10 (over 9.8 million people).
More data from Cuba will be released in the coming years regarding the leptospirosis and other interventions, such as their new HP immunisation against Dengue Fever (for which there is no vaccine available).
This immunization program undertaken by the Finlay Institute (a W.H.O. registered vaccine manufacturer) cost around $400,000US. It indicates that the entire population of Australia could be homoeopathically immunised for around $10,000,000. This cost applies for homeopathic immunization against any infectious disease. In 2009, the Australian Government spent $200,000,000 to purchase vaccines (mostly unused) to vaccinate the Australian population against Swine Flu. In fact, most of this expenditure could have been saved using homeopathic immunization against Swine Flu, and this calculation can be repeated many times given the large vaccination schedule now current in Australia. But further, the homeopathic option is non-toxic, and would remove the risk of using a little tested vaccine. We know in America when mass swine flu vaccination was last used that people died from the vaccine and hundreds were permanently damaged, costing the American Government billions in compensation.
Connect With Us